"Designing Growth Strategies is in our DNA"

Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI100707

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global nebulizer market size was valued at USD 909.7 million in 2019 and is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period.

COVID-19 Cover

This report covers COVID-19 impact analysis on Nebulizers Market

Inquire before buying

A nebulizer is a drug delivery device which enables the administration of medication in the form of mist into the lungs. These devices pump pressurized air through the liquid to form a fine mist, which is breathed in through a mouthpiece or mask. These machines are designed for the treatment of asthma, cystic fibrosis, COPD, and other respiratory disorders. Growing incidence of respiratory disorders globally and the rise in the patient population are likely to fuel the market growth during the forecast period. Rising demand for innovative respiratory drug delivery devices and the rapid adoption of these devices among patient population are likely to drive their usage during the forecast period.


Currently, the COVID-19 pandemic outbreak across the globe has accelerated the demand for devices to efficiently control the spread of this respiratory infection. Since the treatment for this infection is currently unavailable, critical care medical equipment are playing a vital role in pain management in patients suffering with COVID-19 infection, mainly in the form of  shortness of breath. As the coronavirus cases accelerate, many countries are facing critical shortage of ventilators and meter dose inhalers. However, there are concerns raised on the safety profile of respiratory devices for transmission of the infection. According to a recent report by the Asthma and Allergy Foundation of America (AAFA), these devices, when used on the patients with COVID-19 in hospitals, are likely to increase the risk of transmission of infections among patients as well as healthcare professionals. However, many pharmaceutical companies are focusing on the development of effective therapies for the treatment of the Covid- 19 infection, which will be chiefly administered via these devices. For instance, Ampio Pharmaceuticals Inc. is currently studying the potential benefit of nebulized treatment using Ampion in SARS-CoV-2-induced acute respiratory distress syndrome. The generation of positive response from clinical study is anticipated to propel the nebulizer market growth. Moreover, if medical device companies strongly emphasize on the development of advanced devices in this segment that reduce the generation aerosols, then there is a stronger possibility of upsurge in the growth of this market amid the coronavirus pandemic.


MARKET TRENDS


Request a Free sample to learn more about this report.


Strong Focus by Market Players on the Development of Highly Advanced Devices


Growing innovations and investments by players for the development of technologically advanced devices has played a major role in increased accessibility of these devices to patients, healthcare providers, and other end users. For instance, Omron Healthcare, Inc. offers OMRON MicroAIR U100, a battery operated portable device for the treatment of respiratory conditions from a simple cough to asthma. The MicroAIR U100 has 360-degree operation which enables its usage in any position and makes it highly comfortable for smaller children. Moreover, the device uses unique mesh technology to deliver the medication to the lungs effectively. Such innovative devices are likely to accelerate the demand for these portable devices at a rapid pace. Additionally, rising awareness among healthcare providers about innovative products along with the increase in collaborations among players to extend their market reach are anticipated to accelerate the market growth.


MARKET DRIVERS


Increasing Incidence of Respiratory Disorders is anticipated to propel the Market Growth


Respiratory illnesses have become a major concern around the globe. Rising burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and increasing adoption of sedentary lifestyle are likely to accelerate the demand for effective drug delivery devices, further propelling this market growth. According to a report published by Forum of International Respiratory Societies (FIRS), in 2019, around 384 million people suffered from chronic obstructive pulmonary disease (COPD) and the number of cases is anticipated to surge in the coming years.  A significant growth in population along with the rise in air pollution and increase in the smoking rates in the emerging economies are anticipated to escalate the incidence of respiratory diseases in emerging countries. Moreover, the changing pattern of asthma with the age and rise in the incidence childhood asthma are likely to boost the usage of portable devices during the forecast period. According to American Lung Association (ALA), in 2016 in the U.S., approximately 3.5 million children below 18 years suffered an asthma attack. The increasing incidence of asthma in children is anticipated to fortify the demand for these devices during the forecast period.


Moreover, growing emphasizes on research and development activities by market players for the introduction of innovative products is likely to drive the market growth during the forecast period.


Growing Adoption of Home Healthcare Devices to Upsurge the demand for these Devices


Rising cost of healthcare services and hospital stays has led to a shift in patient treatment towards home settings, thus increasing the adoption of breathable medical devices for home healthcare. Growing demand for effective inhaled drug delivery devices and the promotion of respiratory care devices for home use by many healthcare organizations are likely to boost the growth of this market during the forecast period.


MARKET RESTRAINT


Presence of Alternate Treatment Options to Restrict the Market Growth


This is a mature market and is likely to face competition with growing acceptance of substitute devices for treatment of respiratory disorders by patients. There is an increasing preference from healthcare providers towards inhalers including metered dose inhalers for asthma treatment. The clinical and operational benefits of MDIs in treatment of asthma, along with lower cost of these devices, has witnessed a growing shift of patients from towards inhalers. Moreover, limited reimbursement policies in developing economies and the higher cost of these devices based on mesh and ultrasonic techniques, are likely to hamper the market during the forecast period.


SEGMENTATION


By Product Analysis


To know how our report can help streamline your business, Speak to Analyst


Jet Nebulizers to Hold Leading Position in the Global Market


Based on product type, the market is segmented into jet, mesh, and ultrasonic nebulizer. The jet nebulizer segment dominated the market share in 2019, largely owing to their low cost. Moreover, presence of large number of players with strong product offerings in jet or pneumatic devices is likely to play significant role in the dominance of this segment throughout the forecast period. The mesh segment is likely to grow at a significant rate during the forecast period. Growing popularity of these devices with mesh technology, owing to the technological advancements, portability, and ease of use are likely to boost the segment’s growth during the forecast period. Moreover, their capability to deliver medication accurately and rising partnerships among key players with an aim to introduce effective devices are likely to drive the growth of the segment.


The ultrasonic nebulizer segment is anticipated to have steady growth. The inability of ultrasonic devices to aerosolize viscous solutions and the low advantages offered by these devices over their jet counterparts have made them less popular among patients and healthcare providers.


By Modality Analysis


Portable Segment to Witness Significant Growth in the Market during the Forecast Period


In terms of modality, the market is segmented into portable and table-top. The market is dominated by the table-top devices and this segment is expected to account for the largest share during forecast period. Major factors contributing to the higher share of the segment include increase in the usage of table-top devices due to operational benefits offered by these devices, and the presence of large number of players with strong table-top devices portfolio.


The portable segment is anticipated to witness substantial growth during the forecast period. Distinct features offered by these devices, including small size of the device making it easy to use at home, are likely to increase the demand for these devices during the forecast period. Growing number of players in the development of portable devices and their rising adoption are likely to boost the portable segment growth at a significant rate during the forecast period.


By End User Analysis


Homecare Setting Segment to Gain Popularity during the Forecast Period


In terms of end user, the market is segmented into hospitals, clinics, and homecare settings. The market is dominated by the hospitals segment. Rising number of private respiratory care clinics and the rise in the adoption of advanced technologies in clinics for respiratory care are likely to support the growth of clinic segment.  Rising demand for home care devices, owing to growing number of patients being treated in these settings, is likely to fuel the homecare setting segment growth during the forecast period. These factors along, with introduction of portable medical devices suitable for home care use, are fueling the demand and adoption on these devices in home care settings.


REGIONAL ANALYSIS


North America Nebulizer Market Size, 2016-2027 (USD million)

To get more information on the regional analysis of this market, Request a Free sample


The market size in North America stood at USD 308.4 million in 2019. A higher prevalence of asthma, and other chronic respiratory conditions, along with rising adoption of advanced portable devices in the region, have been instrumental in higher share of North America in the global market. According to the Centers for Disease Control and Prevention (CDC), every 1 in 13 people in the country are suffering from asthma. This equates to an estimated 25 million people in the U.S., suffering from asthma. Moreover, adequate reimbursement policies for these devices in the region is likely to boost the market growth in the region. The market in Asia-Pacific is driven by the rising prevalence of chronic respiratory diseases, improving healthcare infrastructure, and growing number of medical device companies developing inhaled drug delivery devices for the treatment of asthma and COPD. On the other side, the market in Latin America and Middle East & Africa is likely to grow at a slower pace. The rapid rise in the prevalence of asthma and COPD is likely to accelerate the demand for these devices for the management of the chronic respiratory diseases in the respective regions during the forthcoming years.


KEY INDUSTRY PLAYERS


Presence of Innovative Devices Allows Players to Establish Strong Foothold in the Market


The competitive landscape indicates presence of a fragmented market. Omron Healthcare, Inc., Koninklijke Philips N.V., and PARI Respiratory Equipment, Inc. are among the top players in the market. The players are majorly focus on the development of innovative devices and entering into strategic partnerships and collaborations to strengthen their position in this market.


Moreover, the market is further characterized by a large proportion of small manufacturers in emerging nation focusing on the development relatively lower cost devices. Other key players offering wide portfolio in the market include DeVilbiss Healthcare LLC, BRIGGS HEALTHCARE, GF HEALTH PRODUCTS, INC., Trudell Medical International, Allied Healthcare Products, Inc., Teleflex Medical, Inc., and Others


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • October 2018 –   Koninklijke Philips N.V. announced the launch of InnoSpire Go, the smallest and lightest portable hand-held nebulizer, in the USA. With the help of vibrating mesh technology, InnoSpire Go is capable of delivering medication to patients suffering from asthma or COPD within four minutes, thus providing patients of all age groups with effective and fast medication delivery.

  • May 2018 –   Convexity Scientific Inc., announced the launch of Flyp nebulizer, a portable & pocket sized device integrated with vibrating mesh technology for patients with asthma and chronic obstructive pulmonary disease.


REPORT COVERAGE


The nebulizer market report provides a detailed analysis of the market and focuses on key aspects such as technological advancements in these devices, prevalence of asthma, and chronic obstructive pulmonary disease (COPD). Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.


To gain extensive insights into the market, Request for Customization


Report Scope & Segmentation











































 ATTRIBUTE



 DETAILS



Study Period



  2016-2027



Base Year



  2019



Forecast Period



  2020-2027



Historical Period



  2016-2018



Unit



  Value (USD million)



Segmentation



By Type



  • Jet Nebulizer

  • Ultrasonic Nebulizer

  • Mesh Nebulizer



By Modality



  • Portable

  • Table-top



By End user



  • Hospitals

  • Clinics

  • Homecare Settings



By Geography



  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • Middle East & Africa (GCC, South Africa, and Rest of  Middle East & Africa)



Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 909.7 million in 2019 and is projected to reach USD 1,778.8 million by 2027.

In 2019, the market value stood at USD 909.7 million.

Growing at a CAGR of 8.1%, the market will exhibit steady growth in the forecast period.

The jet Nebulizer segment is expected to be the leading segment type in this market during the forecast period.

Rising incidence of chronic respiratory diseases, increasing adoption of homecare medical devices, and growing advancements in these devices are some of the key factors driving the market.

Omron Healthcare, Inc., Koninklijke Philips N.V., and PARI Respiratory Equipment, Inc. are among the top players in the market.

North America dominated the market share in 2019.

Nebulizers Market Size, Share and Global Industry Trend Forecast till 2026
  • May, 2020
  • 2019
  • 2016-2018
  • 150

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X